Results 81 to 90 of about 15,220 (305)

High acceptability of voluntary counselling and HIV-testing but unacceptable loss to follow up in a prevention of mother-to-child HIV transmission programme in rural Malawi: scaling-up requires a different way of acting. [PDF]

, 2005
SETTING: Thyolo District Hospital, rural Malawi. OBJECTIVES: In a prevention of mother-to-child HIV transmission (PMTCT) programme, to determine: the acceptability of offering 'opt-out' voluntary counselling and HIV-testing (VCT); the progressive loss to
Brahmbhatt, Bulterys, Caballero-Gordo, Graham, Graham, Green, Guay, Isenalumbe, MOHP, MOHP, MOHP, MOHP, Newell, Nolan, NSO, Stringer, Sweat, Taha, Taha, UNAIDS/WHO, VCT group, Walraven, WHO, WHO/UNAIDS, World Health Organization (WHO), Zachariah, Zachariah   +26 more
core   +2 more sources

Pharmacokinetics and adverse effects of a long‐acting IM dopamine agonist: Cabergoline in healthy horses

Equine Veterinary Education, EarlyView.
Summary Background Pituitary pars intermedia dysfunction (PPID) is commonly treated with pergolide mesylate, a dopamine receptor agonist. Cabergoline is a dopamine receptor agonist that has shown activity on prolactin secretion in horses for up to 10 days.
H. Hess, A. Bracken, S. Rao, Y. Nout‐Lomas, D. Gustafson, L. Bass   +5 more
wiley   +1 more source

A possible role of GDNF expression by which cabergoline use affects corpus callosum

Journal of Pediatric and Neonatal Individualized Medicine, 2018
A variety of malformations have been associated with cabergoline use during gestation. Recently we had a preterm male infant referred to our Neonatal Intensive Care Unit diagnosed with corpus callosum agenesis confirmed by brain ultrasound and brain ...
Georgios Mitsiakos, Anastasia Gkampeta
doaj   +1 more source

Protective Role of Sarpogrelate in Combination with Bromocriptine and Cabergoline for Treatment of Diabetes in Alloxan-induced Diabetic Rats

Current Therapeutic Research, 2021
: Background: Although dopamine D2 receptor agonists, bromocriptine and cabergoline, are notable medications in the treatment of Parkinsonism, hyperprolactinemia, and hyperglycemia, there is an identified relationship between the utilization of D2-like ...
Mohammed Fouad Shalaby, MD, Hekma A. Abd El Latif, PhD, Mohamed El Yamani, PhD, May Ahmed Galal, PhD, Sherifa Kamal, PhD, Ikhlas Sindi, PhD   +5 more
doaj   +1 more source

Development of a health‐related quality‐of‐life assessment tool for equines with pituitary pars intermedia dysfunction

Equine Veterinary Journal, EarlyView.
Abstract Background Clinical signs of pituitary pars intermedia dysfunction (PPID) are frequently mistaken for ‘normal’ ageing and may not be optimally assessed. Objective quality of life (QoL) assessment could improve clinical decision‐making. Objectives To develop an owner‐reported health‐related quality‐of‐life (HRQoL) assessment tool for equines ...
Aline Bouquet, Christine Nicol, Edward J. Knowles, Imogen Schofield, Nicola J. Menzies‐Gow   +4 more
wiley   +1 more source

Predictors of chronic LH-testosterone axis suppression in male macroprolactinomas with normoprolactinemia on cabergoline.

Journal of Clinical Endocrinology and Metabolism, 2020
CONTEXT Data regarding prevalence, predictors, and mechanisms of persistent hypogonadotropic hypogonadism (HH) in males with a macroprolactinoma who achieve normoprolactinemia on dopamine-agonist therapy is limited.
Manjeetkaur Sehemby, A. Lila, V. Sarathi, Ravikumar Shah, Shilpa Sankhe, Sanjeet Kumar Jaiswal, Swati Ramteke-Jadhav, Virendra A. Patil, N. Shah, T. Bandgar   +9 more
semanticscholar   +1 more source

Place of Cabergoline in Acromegaly: A Meta-Analysis [PDF]

The Journal of Clinical Endocrinology & Metabolism, 2011
Context: Cabergoline is widely considered to be poorly effective in acromegaly. Objective: The aim of this study was to obtain a more accurate picture of the efficacy of cabergoline in acromegaly, both alone and in combination with somatostatin ...
Philippe Chanson, Laure Sandret, Patrick Maison   +2 more
openaire   +3 more sources

Cabergoline for preventing ovarian hyperstimulation syndrome in women at risk undergoingin vitro fertilization/intracytoplasmic sperm injection treatment cycles: A randomized controlled study

Avicenna Journal of Medicine, 2015
Background: Ovarian hyperstimulation syndrome (OHSS) is the most serious and potentially life-threatening iatrogenic complication associated with ovarian stimulation during assisted reproductive technology protocols. The aim of this study was to evaluate
Niyazi Kilic, Özhan Özdemir, Hakan Cevdet Başar, Fadime Demircan, Fırat Ekmez, Oğuz Yücel   +5 more
doaj   +1 more source

Diabetes mellitus secondary to Cushing's disease [PDF]

, 2018
Associated with important comorbidities that significantly reduce patients’ overall wellbeing and life expectancy, Cushing’s disease (CD) is the most common cause of endogenous hypercortisolism.
Barbot, Mattia, Ceccato, Filippo, Scaroni, Carla   +2 more
core   +2 more sources

Dopamine and prolactin in migraine: Mechanisms and potential therapeutic targets

Journal of Neuroendocrinology, EarlyView.
Prolactin and dopamine modulate migraine‐relevant trigeminal pathways. Hyperprolactinemia is associated with migraine‐like headache, and preclinical studies show that prolactin enhances trigeminal excitability, particularly in females. Dopamine inhibits prolactin release and may also directly suppress trigeminovascular activity via D2 receptors in the ...
Astrid Johannesson Hjelholt, Randi Maria Hanghøj Tei, Hans Christoph Diener, Jens Otto Lunde Jørgensen   +3 more
wiley   +1 more source